316 related articles for article (PubMed ID: 32397231)
1. Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines.
Anderluzzi G; Lou G; Gallorini S; Brazzoli M; Johnson R; O'Hagan DT; Baudner BC; Perrie Y
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32397231
[TBL] [Abstract][Full Text] [Related]
2. Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.
Lou G; Anderluzzi G; Schmidt ST; Woods S; Gallorini S; Brazzoli M; Giusti F; Ferlenghi I; Johnson RN; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2020 Sep; 325():370-379. PubMed ID: 32619745
[TBL] [Abstract][Full Text] [Related]
3. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446
[TBL] [Abstract][Full Text] [Related]
4. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.
Henriksen-Lacey M; Christensen D; Bramwell VW; Lindenstrøm T; Agger EM; Andersen P; Perrie Y
Mol Pharm; 2011 Feb; 8(1):153-61. PubMed ID: 21117621
[TBL] [Abstract][Full Text] [Related]
6. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
7. Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses.
Anderluzzi G; Schmidt ST; Cunliffe R; Woods S; Roberts CW; Veggi D; Ferlenghi I; O'Hagan DT; Baudner BC; Perrie Y
J Control Release; 2021 Feb; 330():933-944. PubMed ID: 33152394
[TBL] [Abstract][Full Text] [Related]
8. Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids.
Ma X; Wu F; Peng C; Chen H; Zhang D; Han T
Biotechnol J; 2023 Nov; 18(11):e2300123. PubMed ID: 37545293
[TBL] [Abstract][Full Text] [Related]
9. Lipoplexes formulation and optimisation: in vitro transfection studies reveal no correlation with in vivo vaccination studies.
McNeil SE; Vangala A; Bramwell VW; Hanson PJ; Perrie Y
Curr Drug Deliv; 2010 Apr; 7(2):175-87. PubMed ID: 20158478
[TBL] [Abstract][Full Text] [Related]
10. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
11. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
12. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants.
Blakney AK; McKay PF; Ibarzo Yus B; Hunter JE; Dex EA; Shattock RJ
ACS Nano; 2019 May; 13(5):5920-5930. PubMed ID: 31046232
[TBL] [Abstract][Full Text] [Related]
13. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
14. Optimization of Lipid Nanoformulations for Effective mRNA Delivery.
Chen H; Ren X; Xu S; Zhang D; Han T
Int J Nanomedicine; 2022; 17():2893-2905. PubMed ID: 35814615
[TBL] [Abstract][Full Text] [Related]
15. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA.
Blakney AK; McKay PF; Christensen D; Yus BI; Aldon Y; Follmann F; Shattock RJ
J Control Release; 2019 Jun; 304():65-74. PubMed ID: 31071377
[TBL] [Abstract][Full Text] [Related]
16. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA.
Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Pozo-Rodríguez AD; Solinís Aspiazu MÁ
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352904
[TBL] [Abstract][Full Text] [Related]
17. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.
Kim SY; Lee SJ; Kim JK; Choi HG; Lim SJ
Int J Nanomedicine; 2017; 12():7323-7335. PubMed ID: 29070949
[TBL] [Abstract][Full Text] [Related]
18. Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines.
Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111658
[TBL] [Abstract][Full Text] [Related]
19. Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity.
van den Berg JH; Oosterhuis K; Hennink WE; Storm G; van der Aa LJ; Engbersen JF; Haanen JB; Beijnen JH; Schumacher TN; Nuijen B
J Control Release; 2010 Jan; 141(2):234-40. PubMed ID: 19751778
[TBL] [Abstract][Full Text] [Related]
20. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
